img

Global Veterinary Dermatology Drugs Market Size By Animal (Companion Animal, Livestock Animal), By Route Of Administration (Topical, Injectable), By Indication (Parasitic Infections, Allergic Infections, Skin Cancer), By Geographic Scope And Forecast


Published on: 2024-08-08 | No of Pages : 320 | Industry : latest updates trending Report

Publisher : MIR | Format : PDF&Excel

Global Veterinary Dermatology Drugs Market Size By Animal (Companion Animal, Livestock Animal), By Route Of Administration (Topical, Injectable), By Indication (Parasitic Infections, Allergic Infections, Skin Cancer), By Geographic Scope And Forecast

Veterinary Dermatology Drugs Market Size And Forecast

Veterinary Dermatology Drugs Market size was valued at USD 7.76 Billion in 2021 and is projected to reach USD 20.74 Billion by 2030, growing at a CAGR of 10% from 2023 to 2030.

The global veterinary medicine industry has been driven by various factors including a rise in the prevalence of different diseases in animals as well as a growing market for farm animals. In addition, the rise in the number of pet owners is driving the need for better possible treatments for companion animals across the globe. The Global Veterinary Dermatology Drugs Market report provides a holistic evaluation of the market. The report comprises various segments as well as an analysis of the trends and factors that are playing a substantial role in the market.

Global Veterinary Dermatology Drugs Market Definition

Veterinary Dermatology is includes diseases affecting the ears, claws, oral and anogenital mucous membranes, hair coat, and subcutaneous tissues of animals. A Veterinary dermatologist is an expert who specializes in the diagnosis, treatment, and management of animal skin, ears, hair, nail, hoof and mouth. Skin conditions in dogs and some cats is a common concern, however, there are a wide range of skin irritations and diseases that can develop from various causes. These conditions also range from mild irritation to extreme pain, if let untreated. Some of the common symptoms of skin irritations in animals are Dull or greasy coat, Hair thinning, Red, watery eyes, Redness, Scabbed, scaly or flaky skin, and Sores or swollen areas.

Veterinary medicines are used to promote or maintain the health of animal species, whether or not they are raised for food. In addition to food-producing animals, they are created and manufactured to cover a wide range of prophylactic and therapeutic objectives. They are given to exotic species, family pets, and wild animals. Most nations have a government regulatory agency in charge of evaluating veterinary medicines and issuing some sort of marketing permission before a product can be sold, and the UK’s system is used to demonstrate this in practice.

Pet veterinary drugs are a type of medicine that deals with preventative measures, disease, and injury of animals, as well as the testing and treatment of disease. Some pet veterinary drugs are similar to human drugs; even so, advances in the development have resulted in numerous specialties within the field, such as areas of expertise including internal medicine, ophthalmology, surgical intervention, radiology, dermatology, cardiology, neurology, and neurosurgery, as well as emergency treatment.

Global Veterinary Dermatology Drugs Market Overview

Additionally, expanding companion animal markets brought on by widespread pet adoption and an increase in the number of veterinarians globally are anticipated to fuel demand for these systems during the ensuing years. The need for precise and efficient diagnostic technologies, which are anticipated to drive market expansion, is a result of an increase in the prevalence of Parasitic Infections, and Allergic Infections.

As evidenced by emerging programs like the One Health Initiative, which recognizes the synergy and potential benefits of promoting collaboration among veterinarians, physicians, as well as other scientific health professionals to develop strategies to advance healthcare, public awareness of the interconnectedness of animal and human health is growing. Changing pet ownership trends, the increased emphasis placed on the human-animal link, and the function of that bond in supporting human health, especially mental health, and well-being, are all important considerations.

There is a limited supply of drugs in the Veterinary Dermatology Drugs Market, as well as importing problems due to the lack of a streamlined system. Additionally, pet parents are more open to alternative therapies including aromatherapy, reflexology, and naturopathy, which are restricting overall growth. Moreover, The high cost of veterinary drugs and therapies Moreover, rising occurrences of diseases in pets including diabetes, obesity, heart disease, arthritis, and premature death necessarily require innovative veterinary treatment options and care from pet owners leading to limiting the overall growth of the market.

Market Attractiveness

The image of market attractiveness provided would further help to get information about the region that is majorly leading in the global Veterinary Dermatology Drugs Market. We cover the major impacting factors that are responsible for driving the industry growth in the given region.

Porter’s Five Forces

The image provided would further help to get information about Porter’s five forces framework providing a blueprint for understanding the behavior of competitors and a player’s strategic positioning in the respective industry. Porter’s five forces model can be used to assess the competitive landscape in the global Veterinary Dermatology Drugs Market, gauge the attractiveness of a certain sector, and assess investment possibilities.

Global Veterinary Dermatology Drugs Market Segmentation Analysis

The Global Veterinary Dermatology Drugs Market is segmented on the basis of Animal, Route Of Administration, Indication, And Geography.

Veterinary Dermatology Drugs Market, By Animal

  • Companion Animal
  • Livestock Animal

Based on Animal, the market is segmented into Companion Animal and Livestock Animal. dermatology drugs are used to treat skin infections or skin diseases in animals mostly companion animals and livestock animals. The companion animal segment is further divided into dogs, cats, horses, and others. The livestock animal segment includes cattle and others.

Veterinary Dermatology Drugs Market, By Route Of Administration

  • Topical
  • Injectable
  • Oral

Based on Route Of Administration, the market is segmented into Topical, Injectable, and Oral. The topical segment is anticipated to capture the largest market as it is one of the oldest methods of administering drugs to control various diseases.

Veterinary Dermatology Drugs Market, By Indication

  • Parasitic Infections
  • Allergic Infections
  • Skin Cancer
  • Others

Based on Indication, the market is segmented into Parasitic Infections, Allergic Infections, Skin Cancer, and Others. Globally, most animals are affected by major skin diseases such as parasitic skin diseases, dander-related skin disorders, alopecia, intrinsic skin infections, mild to harmful skin cancer, autoimmune skin diseases, and other skin abnormalities. The rising number of pet owners with additional pet care decisions is adding up to the growth of the Veterinary Dermatology Drugs Market in this segment.

Veterinary Dermatology Drugs Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

On the basis of Geography, the Global Veterinary Dermatology Drugs Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America is projected to be the highest-growing market segment. Increased adoption of pet health insurance in the United States is also anticipated to fuel the growth. The increased concentration of major veterinary hospitals in this region providing excellent reimbursement rates is fueling the market growth. Consolidation of large healthcare professionals also drives market growth and increases the buying power of healthcare professionals, culminating in scale economies. The concentration of big veterinary hospitals in this region that offer competitive reimbursement rates is fueling the market growth. Because of the increased buying power of healthcare providers, which results in economies of scale, the market grows as a result of the consolidation of large healthcare.

Key Players

The “Global Veterinary Dermatology Drugs Market” study report will provide valuable insight with an emphasis on the global market including some of the major players Bayer, Bimeda, Inc., Merk & Co. Inc, Virbac, Ceva Santé Animale, Mars Incorporated (Virginia, USA), Zoetis, Inc., Nestle S.A. and others.

Our market analysis also entails a section solely among others. Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide insight to the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key development

  • In September 2022, Zoetis Inc world’s leading animal health company announced the completion of of Jurox, an animal health company that develops, manufactures, and markets a wide range of veterinary medicines for treating livestock and companion animals. The acquisition will increase the company’s range of products, with the potential for greater expansion in the global market.
  • In May 2021, Elanco Animal Health Incorporated, launched Credelio Cat, the first oral flea and tick product for cats. It is a small, chewable product that protects against black-legged ticks throughout the month in cats 6 months and older. It is a successful product and was administered by 99.5% of cat owners in a U.S. field study.
  • In August 2020, Elanco purchased Bayer’s Animal Health Business for USD 6.89 billion, funded by USD 5.17 billion in cash and 72.9 million shares to Bayer. Through this acquisition the company plans to increase company’s scale and capabilities, positioning it as a long-term leader in the lucrative and long-lasting animal health business.

Ace Matrix Analysis

The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of services, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into four categories as Active, Cutting Edge, Emerging, and Innovators.

Report Scope

REPORT ATTRIBUTESDETAILS
Study Period

2018-2030

Base Year

2021

Forecast Period

2023-2030

Historical Period

2018-2020

Unit

Value (USD Billion)

Key Companies Profiled

Bayer, Bimeda, Inc., Merk & Co. Inc, Virbac, Ceva Santé Animale, Mars Incorporated (Virginia, USA), Zoetis, Inc., Nestle S.A.

Segments Covered

By Animal, By Route Of Administration, By Indication, And By Geography.

Customization scope

Free report customization (equivalent up to 4 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope.

Top Trending Reports

Research Methodology of Market Research

To k

Table of Content

To get a detailed Table of content/ Table of Figures/ Methodology Please contact our sales person at ( chris@marketinsightsresearch.com )
To get a detailed Table of content/ Table of Figures/ Methodology Please contact our sales person at ( chris@marketinsightsresearch.com )